ConductScience.org, home

Paper41515935

Modified mRNA-Based Therapeutic Strategies for Myocardial Ischemia-Reperfusion Injury.

Cai T and 1 other. Int J Mol Sci, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Modified mRNA-Based Therapeutic Strategies for Myocardial Ischemia-Reperfusion Injury. Papers, record 41515935. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41515935

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Modified mRNA-Based Therapeutic Strategies for Myocardial Ischemia-Reperfusion Injury.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-06-25
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cai TTing
2Yang XQXiang-Qunhttps://orcid.org/0000-0001-6002-2218

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Myocardial Reperfusion InjuryMajor topic
RNA, MessengerMajor topic
Genetic TherapyMajor topic
Humans
Animals

References129

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135317048Follistatin-like 1 promotes proliferation of matured human hypoxic iPSC-cardiomyocytes and is secreted by cardiac fibroblasts.Mol Ther Methods Clin Dev2022https://conductscience.org/library/papers/35317048PubMed
225628647Regulation of IGF -1 signaling by microRNAs.Front Genet2014https://conductscience.org/library/papers/25628647PubMed
334478633Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease.Cell Metab2021https://conductscience.org/library/papers/34478633PubMed
433929904Assessing the Association of Mitochondrial Function and Inflammasome Activation in Murine Macrophages Exposed to Select Mitotoxic Tri-Organotin Compounds.Environ Health Perspect2021https://conductscience.org/library/papers/33929904PubMed
522651554Ischemic preconditioning promotes intrinsic vascularization and enhances survival of implanted cells in an in vivo tissue engineering model.Tissue Eng Part A2012https://conductscience.org/library/papers/22651554PubMed
624018375Driving vascular endothelial cell fate of human multipotent Isl1+ heart progenitors with VEGF modified mRNA.Cell Res2013https://conductscience.org/library/papers/24018375PubMed
736744541Diversity of cells and signals in the cardiovascular system.J Physiol2023https://conductscience.org/library/papers/36744541PubMed
825774921Catestatin exerts direct protective effects on rat cardiomyocytes undergoing ischemia/reperfusion by stimulating PI3K-Akt-GSK3β pathway and preserving mitochondrial membrane potential.PLoS One2015https://conductscience.org/library/papers/25774921PubMed
939831819Extracellular vesicle-mediated VEGF-A mRNA delivery rescues ischaemic injury with low immunogenicity.Eur Heart J2025https://conductscience.org/library/papers/39831819PubMed
1034129954Ultrasound-assisted C3F8-filled PLGA nanobubbles for enhanced FGF21 delivery and improved prophylactic treatment of diabetic cardiomyopathy.Acta Biomater2021https://conductscience.org/library/papers/34129954PubMed
1124332029The interleukin-1 family: back to the future.Immunity2013https://conductscience.org/library/papers/24332029PubMed
1239836346Melatonin inhibits ferroptosis through the ATF3/GPX4 signaling pathway to relieve myocardial ischemia-reperfusion injury in rats.In Vitro Cell Dev Biol Anim2025https://conductscience.org/library/papers/39836346PubMed
1325588055Synthetic chemically modified mrna-based delivery of cytoprotective factor promotes early cardiomyocyte survival post-acute myocardial infarction.Mol Pharm2015https://conductscience.org/library/papers/25588055PubMed
1440288393Co-occurrence patterns and related risk factors of ischaemic heart disease and ischaemic stroke across 203 countries and territories: a spatial correspondence and systematic analysis.Lancet Glob Health2025https://conductscience.org/library/papers/40288393PubMed
1531391918PKM2, function and expression and regulation.Cell Biosci2019https://conductscience.org/library/papers/31391918PubMed
1637954462Stem Cell-Based Therapy and Cell-Free Therapy as an Alternative Approach for Cardiac Regeneration.Stem Cells Int2023https://conductscience.org/library/papers/37954462PubMed
1737556386Mitochondrial pannexin1 controls cardiac sensitivity to ischaemia/reperfusion injury.Cardiovasc Res2023https://conductscience.org/library/papers/37556386PubMed
1836902165Modified mRNA as a Treatment for Myocardial Infarction.Int J Mol Sci2023https://conductscience.org/library/papers/36902165PubMed
19350396712021 FDA approvals: value driven by COVID-19 vaccines.Nat Rev Drug Discov2022https://conductscience.org/library/papers/35039671PubMed
2030793306VEGF-A promotes angiogenesis after acute myocardial infarction through increasing ROS production and enhancing ER stress-mediated autophagy.J Cell Physiol2019https://conductscience.org/library/papers/30793306PubMed

See all 129 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42941960N1-Methylpseudouridine-Modified mRNA-Transfected Dendritic Cells Enable Efficient Generation of Functional Tumor Antigen-Specific Cytotoxic T Lymphocytes.Int J Mol Sci2026https://conductscience.org/library/papers/42941960PubMed
42765443mRNA Therapeutics Beyond Infectious Diseases: Expanding Therapeutic Applications and Future Perspectives.Immun Inflamm Dis2026https://conductscience.org/library/papers/42765443PubMed
42146021MiR-200a-3p protects against myocardial ischemia-reperfusion injury via KEAP1-NRF2 signaling.Front Physiol2026https://conductscience.org/library/papers/42146021PubMed
42074166N-p-trans-Coumaroyltyramine Improves Myocardial Ischemia-Reperfusion Injury: From Cellular Protection to Animal Model Validation and the Discovery of the Target Tcap.Int J Mol Sci2026https://conductscience.org/library/papers/42074166PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41515935

GET https://conductscience.org/api/papers/v1/41515935/references?page=2